MarketWatch.com - MarketPulse
NEW YORK (MarketWatch) - Workstream Inc. said Monday it received an unsolicited offer from a U.S.-based payroll business to determine the viability of a merger between the two companies. Any deal will be subject to the standard conditions including the completion of due diligence, regulatory approval, shareholder approval, board approval and the required valuations, Workstream said. Shares last traded at about 65 cents each.
MarketWatch.com - MarketPulse
NEW YORK (MarketWatch) -- Mylan Inc. received final approval from the Food and Drug Administration for its abbreviated drug application for Balsalazide Disodium Capsules to treat ulcerative colitis. The Pittsburgh drug company said the 75 mg Balsalazide capsules is the generic version of Salix Pharmaceuticals Ltd.'s Colazal Capsules, which had U.S. sales of $130.9 million for the year ended Sept. 30.